Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group.

A Kasahara; N Hayashi; K Mochizuki; M Takayanagi; K Yoshioka; S Kakumu; A Iijima; A Urushihara; K Kiyosawa; M Okuda

doi:10.1002/hep.510270529

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group.

NobleID: NI5P57W67R10S64
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/DF9EDC13

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DF9EDC13.svg?ark=w1%2F20260515%2FDF9EDC13&value=id)](https://nobleid.org/work/w1/20260515/DF9EDC13)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group.

NobleID: NI5P57W67R10S64
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/DF9EDC13

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/DF9EDC13.svg?ark=w1%2F20260515%2FDF9EDC13&value=id)](https://nobleid.org/work/w1/20260515/DF9EDC13)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work